Business Acquisition [Axis] Business Acquisition [Axis] Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Net loss on sale of business and other assets Gain (Loss) Disposition Of Business And Other Assets Gain (Loss) Disposition Of Business And Other Assets Pending claims, number Loss Contingency, Pending Claims, Number DEFERRED INCOME TAXES Deferred Income Tax Assets, Net Entity Address, Postal Zip Code Entity Address, Postal Zip Code Finance lease right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Schedule of Shareholders' Equity Schedule of Stockholders Equity [Table Text Block] Euro Deferred Shares Euro Deferred Shares [Member] Euro Deferred Shares [Member] Debt Instrument [Axis] Debt Instrument [Axis] Total finance lease liabilities Finance Lease, Liability Opioid Related Cases and Mesh Related Cases Opioid Related Cases And Mesh Related Cases [Member] Opioid Related Cases And Mesh Related Cases Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Certain litigation-related and other contingencies, net Loss Contingency, Loss in Period Beginning liability balance Ending liability balance Restructuring Reserve Schedule of Assets and Liabilities, Lessee Assets And Liabilities, Lessee [Table Text Block] Assets And Liabilities, Lessee [Table Text Block] Accrued payroll and related benefits Accrued Employee Benefits, Current Additional paid-in capital Additional Paid in Capital Performance obligation satisfied in previous period Contract with Customer, Performance Obligation Satisfied in Previous Period Other Settlement Funds, Other Settlement Funds, Other Acquired in-process research and development Payments to Acquire in Process Research and Development Financial Instruments [Domain] Financial Instruments [Domain] Restrictions on Cash and Cash Equivalents [Table] Restrictions on Cash and Cash Equivalents [Table] Statistical Measurement [Domain] Statistical Measurement [Domain] Other lease costs and income: Operating Lease, Lease Income [Abstract] Euro deferred shares, par value (in dollars per share) Euro Deferred Shares, Par or Stated Value Per Share Euro Deferred Shares, Par or Stated Value Per Share Potential settlement in equity, percent Potential Settlement Made In Equity, Percentage Potential Settlement Made In Equity, Percentage Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Schedule of Components of Other Expense, Net Schedule of Other Nonoperating Income, by Component [Table Text Block] PROPERTY, PLANT AND EQUIPMENT, NET Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Component of Operating Income [Abstract] Component of Operating Income [Abstract] Net loss Net loss Net loss NET LOSS Net Income (Loss) Attributable to Parent Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Measurement Input Type [Domain] Measurement Input Type [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] LEASES Lessee, Finance Leases [Text Block] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Capitalized interest payments Interest Paid, Capitalized, Investing Activities Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Numerator: Earnings Per Share Reconciliation [Abstract] Scenario [Axis] Scenario [Axis] Term Loan Facility Secured Debt [Member] Discount rate Measurement Input, Discount Rate [Member] Fair value of financial assets measured on recurring basis Assets, Fair Value Disclosure Restructuring Plan [Axis] Restructuring Plan [Axis] LEASES Lessee, Operating Leases [Text Block] Amortization of right-of-use assets Finance Lease, Right-of-Use Asset, Amortization Lessee, Lease, Description Lessee, Lease, Description [Line Items] Related Party [Domain] Related Party [Domain] Employee Separation, Continuity and Other Benefit-Related Costs Employee Separation, Continuity, and Other Benefit Related Costs [Member] Employee Separation, Continuity, and Other Benefit Related Costs [Member] Contract assets Contract with Customer, Asset, after Allowance for Credit Loss Product line revenue reporting threshold Product Line Revenue Reporting Threshold Product Line Revenue Reporting Threshold Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Goodwill Goodwill [Line Items] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Level 1 Inputs Fair Value, Inputs, Level 1 [Member] Potential reimbursement closing cost Potential Reimbursement Closing Cost Potential Reimbursement Closing Cost OTHER COMPREHENSIVE INCOME: Other Comprehensive Income (Loss), Net of Tax [Abstract] 5.375% Senior Notes due 2023 Five Point Three Seven Five Senior Notes Due On Two Thousand Twenty Three [Member] Five Point Three Seven Five Senior Notes Due On Two Thousand Twenty Three [Member] 6.00% Senior Notes due 2023 Six Point Zero Percent Senior Notes Due Two Thousand Twenty Three [Member] Six Point Zero Percent Senior Notes Due Two Thousand Twenty Three [Member] Par Pharmaceutical Inc. Par Pharmaceutical Inc. [Member] Par Pharmaceutical Inc. Award Type [Axis] Award Type [Axis] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Net cash provided by operating activities Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Current portion of operating lease liabilities Current operating lease liabilities Operating Lease, Liability, Current Finance lease cost: Lease, Cost [Abstract] Amounts settled Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements ADRENALIN® Adrenalin [Member] Adrenalin [Member] Proceeds from sale of business and other assets Proceeds from Divestiture of Businesses Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] COSTS AND EXPENSES: Costs and Expenses [Abstract] Total segment adjusted income from continuing operations before income tax Total segment adjusted income from continuing operations before income tax Adjusted Income (Loss) Before Income Tax Adjusted income (loss) before income tax. Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Initial settlement payments Litigation Settlement, Initial Settlement Payment Litigation Settlement, Initial Settlement Payment Rebates Accrued Liabilities, Rebates, Current Accrued Liabilities, Rebates, Current PERCOCET® PERCOCET [Member] PERCOCET [Member] Legal Entity [Axis] Legal Entity [Axis] Restructuring and related costs, expected cost savings Restructuring And Related Costs, Expected Cost Savings Restructuring And Related Costs, Expected Cost Savings Aggregate cash consideration from sale of assets Proceeds from Sale of Productive Assets Share-based Compensation Arrangement by Share-based Payment Award Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Geographical [Axis] Geographical [Axis] INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] 7.25% Senior Notes due 2022 Seven Point Two Five Percent Senior Notes Due Two Thousand Twenty Two [Member] Seven Point Two Five Percent Senior Notes Due Two Thousand Twenty Two [Member]. Stay of approval period, Hatch-Waxman Act Loss Contingency Stay Of Approval Period Hatch Waxman Act Loss Contingency Stay Of Approval Period Hatch Waxman Act Staling Horse Bid Staling Horse Bid [Member] Staling Horse Bid Novavax, Inc. Novavax, Inc. [Member] Novavax, Inc. Entity Ordinary Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Domain] Fair Value Hierarchy and NAV [Domain] Total Restructuring Costs and Asset Impairment Charges Revolving Credit Facility Revolving Credit Facility [Member] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Funding commitment related to settlement Loss Contingency, Funding Commitment Related To Settlement Loss Contingency, Funding Commitment Related To Settlement Discontinued operations (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share Document Type Document Type VASOSTRICT and/or ADRENALIN VASOSTRICT and/or ADRENALIN [Member] VASOSTRICT and/or ADRENALIN [Member] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Restructuring Type [Axis] Restructuring Type [Axis] Debtor-in-Possession Reorganization, Chapter 11, Debtor-in-Possession [Member] Employee separation, continuity and other benefit-related costs Severance Costs Segments [Axis] Segments [Axis] DEBT Debt Disclosure [Text Block] Contract with Customer, Asset and Liability [Abstract] Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract] Loss contingency, number of municipalities Loss Contingency, Number of Municipalities Loss Contingency, Number of Municipalities Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Opioid-related matters Opioid Related Cases [Member] Opioid Related Cases [Member] Dexlansoprazole Dexlansoprazole [Member] Dexlansoprazole Certain other restructuring costs Other Restructuring Costs Changes in Fair Value Recorded in Earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustments And Accretion Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustments And Accretion Other Intangible Assets, Other Intangible Assets, Other Developed technology Developed Technology Rights [Member] Financial Instrument [Axis] Financial Instrument [Axis] Schedule of Stockholders' Equity [Table] Schedule Of Stockholders' Equity [Table] Schedule Of Stockholders' Equity Finite-lived intangibles: Finite-Lived Intangible Assets [Roll Forward] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Subsequent event Subsequent Event [Member] Consolidation Items [Domain] Consolidation Items [Domain] Schedule of Contract Assets and Liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Document Period End Date Document Period End Date Income Tax Examination [Table] Income Tax Examination [Table] TOTAL ASSETS Assets Potential settlement in cash Potential Settlement Made In Cash Potential Settlement Made In Cash 5.75% Senior Notes due 2022 Five Point Seven Five Senior Notes Due On Two Thousand Twenty Two [Member] Five Point Seven Five Senior Notes Due On Two Thousand Twenty Two [Member] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] District Court For The Eastern District of Pennsylvania District Court For The Eastern District of Pennsylvania [Member] District Court For The Eastern District of Pennsylvania Reorganization Reorganization, Chapter 11 [Line Items] Schedule of Accounts Payable and Accrued Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Other comprehensive income (loss), tax, portion attributable to parent Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Acquisitions Finite-Lived Intangible Assets Acquired Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities 7.50% Senior Secured Notes due 2027 Seven Point Five Percent Senior Secured Notes Due Twenty Twenty Seven [Member] Seven Point Five Percent Senior Secured Notes Due Twenty Twenty Seven [Member] Fair value of long term debt Long-Term Debt, Fair Value Accounting Policies [Abstract] Accounting Policies [Abstract] Number of cases alleging personal injury and/or wrongful death Loss Contingency, Number Of Cases Alleging Personal Injury And/Or Wrongful Death Loss Contingency, Number Of Cases Alleging Personal Injury And/Or Wrongful Death Interest expense, debt Interest Expense, Debt No Trading Symbol Flag No Trading Symbol Flag Reclassification from AOCI Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Variable lease costs Variable Lease, Cost Other Sterile Injectables Other Sterile Injectables [Member] Other Sterile Injectables [Member] (Gain) loss on sale of business and other assets Gain (Loss) on Disposition of Business INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAX Total consolidated income (loss) from continuing operations before income tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Segments [Domain] Segments [Domain] Deferred income taxes Deferred Income Taxes and Tax Credits Schedule of Goodwill [Table] Schedule of Goodwill [Table] Total right-of-use assets Lease, Right-of-Use Asset Lease, Right-of-Use Asset Gross consideration payable Resolution Settlement, Gross Consideration Payable Resolution Settlement, Gross Consideration Payable Amortization of debt issuance costs and discount Amortization of Debt Issuance Costs and Discounts NET LOSS PER SHARE Earnings Per Share [Text Block] Noncurrent finance lease liabilities Finance Lease, Liability, Noncurrent Disposal group, disposed of by sale, not discontinued operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Loss contingency, claims settled, number Loss Contingency, Claims Settled, Number Schedule of Components of Income (Loss) Tax Benefit Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Award Type [Domain] Award Type [Domain] Restructuring Plan [Domain] Restructuring Plan [Domain] Contingency charges Loss Contingency, Charges Loss Contingency, Charges Income taxes receivable Income Taxes Receivable, Current Entity Registrant Name Entity Registrant Name Restructuring Support Agreement Restructuring Support Agreement [Member] Restructuring Support Agreement Amounts related to continuity and separation benefits, cost reductions and strategic review initiatives Cost Reduction Initiatives Cost Reduction Initiatives SUBSEQUENT EVENT Subsequent Events [Text Block] Restructuring Reserve Restructuring Reserve [Roll Forward] Effect of currency translation Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) San Francisco San Francisco [Member] San Francisco Entity Address, City or Town Entity Address, City or Town Other, net Other Nonrecurring (Income) Expense Liquidity requirement Debt Instrument, Covenant, Liquidity Requirement Debt Instrument, Covenant, Liquidity Requirement Professional fees Debtor Reorganization Items, Legal and Advisory Professional Fees Leases [Abstract] Leases [Abstract] Nevakar Injectables, Inc Nevakar Injectables, Inc. [Member] Nevakar Injectables, Inc. Potential proceeds from settlement of unencumbered assets Potential Proceeds From Settlement Of Unencumbered Assets Potential Proceeds From Settlement Of Unencumbered Assets Minimum Minimum [Member] Restricted cash and cash equivalents Restricted cash and cash equivalents, current Restricted Cash and Cash Equivalents, Current Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Raw materials Inventory, Raw Materials, Net of Reserves Discontinued operations (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share Income Tax Examination Income Tax Examination [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Entity File Number Entity File Number Trade accounts payable Accounts Payable, Trade, Current Accrued interest Interest Payable, Current Inventory adjustments Restructuring And Related Cost, Inventory Adjustments Restructuring And Related Cost, Inventory Adjustments Accelerated depreciation Restructuring and Related Cost, Accelerated Depreciation Disposal Group Classification [Axis] Disposal Group Classification [Axis] Total restricted cash and cash equivalents Restricted Cash and Cash Equivalents Accelerated depreciation Accelerated Depreciation Charges [Member] Accelerated Depreciation Charges Effective tax rate (as a percent) Effective Income Tax Rate Reconciliation, Percent Other Liabilities Subject to Compromise, Other Liabilities Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Settlement funds Beginning balance Ending balance Settlement Funds Settlement Funds 6.00% Senior Notes due 2025 Six Percent Senior Notes Due Two Thousand Twenty Five [Member] Six Percent Senior Notes Due Two Thousand Twenty Five Use of Estimates Use of Estimates, Policy [Policy Text Block] Beginning of period End of period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Concentration risk, percentage Concentration Risk, Percentage Subsequent Events [Abstract] Subsequent Events [Abstract] Varenicline Tablets Varenicline Tablets [Member] Varenicline Tablets Restructuring and related cost, cost incurred to date Restructuring and Related Cost, Cost Incurred to Date 9.50% Senior Secured Second Lien Notes due 2027 Nine Point Five Percent Senior Notes Due Two Thousand Twenty Seven [Member] Nine Point Five Percent Senior Notes Due Two Thousand Twenty Seven Amount of claims filed excluding repetitive claims Bankruptcy Claims, Amount of Claims Filed Excluding Repetitive Claims Bankruptcy Claims, Amount of Claims Filed Excluding Repetitive Claims Accounts payable, accrued expenses and other liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities RECEIVABLES FROM NON-DEBTOR AFFILIATES Due from Affiliate, Noncurrent INCOME TAXES Income Tax Disclosure [Text Block] Manufacturing facilities Manufacturing Facilities In Chestnut Ridge, NY And Irvine, CA and U.S. Product Regulatory Approvals And Certain Related Product Inventory [Member] Manufacturing Facilities In Chestnut Ridge, NY And Irvine, CA and U.S. Product Regulatory Approvals And Certain Related Product Inventory LOSS FROM CONTINUING OPERATIONS Loss from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Effect of Currency Translation Intangible Assets, Foreign Currency Translation Gain (Loss) Intangible Assets, Foreign Currency Translation Gain (Loss) Finished goods Inventory, Finished Goods, Net of Reserves Credit Facility [Domain] Credit Facility [Domain] Beginning balance Ending balance Intangible Assets, Gross (Excluding Goodwill) Amortization of intangible assets Amortization Amortization expense Amortization of Intangible Assets Schedule of Changes in the Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Basic (in dollars per share) Earnings Per Share, Basic Schedule of Liabilities Subject to Compromise Schedule Of Liabilities Subject To Compromise [Table Text Block] Schedule Of Liabilities Subject To Compromise Cost basis: Other Intangible Assets, Cost Basis [Abstract] Other Intangible Assets, Cost Basis [Abstract] Schedule of Restricted Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Inventory adjustments Inventory Adjustments [Member] Inventory Adjustments Counterparty Name [Domain] Counterparty Name [Domain] Branded Pharmaceuticals Branded Pharmaceuticals Segment [Member] Branded Pharmaceuticals Segment [Member] TLC Agreement TLC Agreement [Member] TLC Agreement Total shareholders’ deficit Shareholders' equity, beginning balance Shareholders' equity, ending balance Stockholders' Equity Attributable to Parent Euro deferred shares, $0.01 par value; 4,000,000 shares authorized and issued at both March 31, 2023 and December 31, 2022 Euro Deferred Stock, Value, Issued Euro Deferred Stock, Value, Issued V A S O S T R I C T Related Matters V A S O S T R I C T Related Matters [Member] V A S O S T R I C T Related Matters Payables to Non-Debtor Affiliates Due to Affiliate, Current Restricted cash and cash equivalents Restricted Cash And Cash Equivalents [Member] Restricted Cash And Cash Equivalents [Member] Entity Interactive Data Current Entity Interactive Data Current Beginning Balance Ending Balance Finite-Lived Intangible Assets, Accumulated Amortization Changes in assets and liabilities which provided (used) cash: Increase (Decrease) in Operating Capital [Abstract] Schedule of Changes to Liability for Acquisition-Related Contingent Consideration Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Money Market Funds Money Market Funds [Member] Generic Pharmaceuticals Generic Pharmaceuticals Segment [Member] Generic Pharmaceuticals Segment [Member] Accumulated Deficit Retained Earnings [Member] Other Established Other Established Products [Member] Other Established Products [Member] SUPPRELIN® LA SUPPRELIN LA [Member] SUPPRELIN LA [Member] Segment Reporting Information Segment Reporting Information [Line Items] Scenario, Plan Scenario, Plan [Member] Litigation-related and other contingencies, net Gain (Loss) Related to Litigation Settlement Lease, cost Lease, Cost Ordinary Shares Common Stock [Member] Total other comprehensive income Other comprehensive income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Schedule of Reorganisation Item in Consolidated Condensed Statements of Operations Schedule Of Reorganisation Item In Consolidated Condensed Statements Of Operations [Table Text Block] Schedule Of Reorganisation Item In Consolidated Condensed Statements Of Operations Astora Astora [Member] Astora [Member] Number of reportable segments Number of Reportable Segments Schedule of Lease, Cost Lease, Cost [Table Text Block] Subsequent settlement payments Litigation Settlement, Subsequent Settlement Payment Litigation Settlement, Subsequent Settlement Payment Repayments of other indebtedness Repayments of Other Long-Term Debt Schedule of Disposal Groups, including Discontinued Operations, Operations Results of Astora Disposal Groups, Including Discontinued Operations [Table Text Block] Effective Interest Rate (as a percent) Debt Instrument, Interest Rate, Effective Percentage Lehigh Valley Technologies, Inc. acquisitions Lehigh Valley Technologies, Inc. [Member] Lehigh Valley Technologies, Inc. [Member] Document Quarterly Report Document Quarterly Report Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations and Disposal Groups [Abstract] CURRENT ASSETS: Assets, Current [Abstract] Liabilities subject to compromise, operating lease liability Liabilities Subject To Compromise, Operating Lease Liability Liabilities Subject To Compromise, Operating Lease Liability OPERATING LEASE LIABILITIES, LESS CURRENT PORTION Noncurrent operating lease liabilities Operating Lease, Liability, Noncurrent Statistical Measurement [Axis] Statistical Measurement [Axis] Payments for contingent consideration Payment for Contingent Consideration Liability, Financing Activities Accumulated deficit Retained Earnings (Accumulated Deficit) Disposal Group Name [Axis] Disposal Group Name [Axis] Cash paid for amounts included in the measurement of lease liabilities: Cash Flow, Lessee [Abstract] Cash Flow, Lessee [Abstract] Other Other Operating Activities, Cash Flow Statement Euro deferred shares, shares issued (in shares) Euro Deferred Shares, Shares Issued Euro Deferred Shares, Shares Issued Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Reorganization items, net Total Reorganization Items Equity Components [Axis] Equity Components [Axis] Scenario [Domain] Scenario [Domain] Fair value, measurements, recurring Fair Value, Recurring [Member] Litigation Case [Domain] Litigation Case [Domain] Cash distributions to settle disputes from Qualified Settlement Funds Settlement Funds, Payments To Plaintiff Counsel From Qualified Settlement Funds Settlement Funds, Payments To Plaintiff Counsel From Qualified Settlement Funds Document Fiscal Year Focus Document Fiscal Year Focus OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Financing cash payments for finance leases Finance Lease, Principal Payments Restricted Cash and Cash Equivalents Restricted Cash and Cash Equivalents Items [Line Items] Other (income) expense, net Other (income) expense, net Nonoperating Income (Expense) Beginning Balance Ending Balance Finite-Lived Intangible Assets, Gross Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Axis] Fair Value Hierarchy and NAV [Axis] Reorganization, Chapter 11 [Table] Reorganization, Chapter 11 [Table] Selling, general and administrative Selling, General and Administrative Expense Inidentifiable Intangible assets Inidentifiable Intangible assets [Member] Inidentifiable Intangible assets Loss Contingencies [Table] Loss Contingencies [Table] Change in fair value of contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability OPERATING LEASE ASSETS Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] OTHER COMPREHENSIVE INCOME Comprehensive Income (Loss) Note [Text Block] Compensation related to share-based awards Employee Benefits and Share-Based Compensation Finance Lease, Liability, Current, Statement of Financial Position [Extensible List] Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Number of product licenses revoked (product) Number Of Product Licenses Revoked Number Of Product Licenses Revoked Type of Restructuring [Domain] Type of Restructuring [Domain] Document Transition Report Document Transition Report Loss contingency, plaintiffs, number of counties Loss Contingency, Plaintiffs, Number Of Counties Loss Contingency, Plaintiffs, Number Of Counties Local Phone Number Local Phone Number Other Specialty Other Specialty Products [Member] Other Specialty Products [Member] Inventories Increase (Decrease) in Inventories Endo International PLC Endo International PLC [Member] Endo International PLC Significant Accounting Policies Added or Updated since December 31, 2022 New Accounting Pronouncements, Policy [Policy Text Block] Prepaid and other assets Increase (Decrease) in Prepaid Expense and Other Assets Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding INVESTMENTS IN NON-DEBTOR AFFILIATES Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures GOODWILL Goodwill, beginning balance Goodwill, ending balance Goodwill Income tax benefit Discontinued Operation, Tax Effect of Discontinued Operation Going Concern Going Concern [Policy Text Block] Going Concern Fair value of financial liabilities measured on recurring basis Liabilities, Fair Value Disclosure Euro deferred shares, shares authorized (in shares) Euro Deferred Shares, Shares Authorized Euro Deferred Shares, Shares Authorized Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Adjustments to reconcile Net loss to Net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] GOODWILL AND OTHER INTANGIBLES Goodwill and Intangible Assets Disclosure [Text Block] INCOME TAX EXPENSE (BENEFIT) Income tax expense (benefit) Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] DEFERRED INCOME TAXES Deferred Income Tax Liabilities, Net Opiod Claimants Opiod Claimants [Member] Opiod Claimants Income Statement [Abstract] Income Statement [Abstract] Additional Paid-in Capital Additional Paid-in Capital [Member] Licenses Licensing Agreements [Member] Document Fiscal Period Focus Document Fiscal Period Focus NET (LOSS) INCOME PER SHARE—BASIC: Earnings Per Share, Basic [Abstract] Number of product licenses (product) Number Of Product Licenses Number Of Product Licenses Diluted (in shares) For diluted per share data—weighted average shares (in shares) Weighted Average Number of Shares Outstanding, Diluted Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Loss Contingencies Loss Contingencies [Line Items] Mesh Liability Accrual Product Liability [Member] Product Liability [Member] Other Finite-lived Intangible Assets, Other Finite-lived Intangible Assets, Other Accounts payable and accrued expenses Total Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Ordinary shares, $0.0001 par value; 1,000,000,000 shares authorized; 235,219,612 and 235,208,039 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively Common Stock, Value, Issued April, 2022 Restructuring Initiative Restructuring Initiative, April 2022 [Member] Restructuring Initiative, April 2022 Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Senior notes Senior Notes [Member] Contract liabilities - % change Contract with Customer, Liability, Increase (Decrease), Percentage Contract with Customer, Liability, Increase (Decrease), Percentage Restricted Cash and Cash Equivalents, Insurance Coverage Restricted Cash And Cash Equivalents, Insurance Coverage [Member] Restricted Cash And Cash Equivalents, Insurance Coverage 2020 Restructuring Initiative Restructuring Initiative, 2020 [Member] Restructuring Initiative, 2020 Schedule of Computation of Diluted Income Per Share Amount Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Operating segments Operating Segments [Member] Accumulated amortization: Finite-Lived Intangible Assets, Accumulated Amortization [Roll Forward] Finite-Lived Intangible Assets, Accumulated Amortization [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Product Concentration Risk Product Concentration Risk [Member] International Pharmaceuticals International Pharmaceuticals Segment [Member] International Pharmaceuticals Segment [Member] Potential settlement made in equity Potential Settlement Made In Equity Amount Potential Settlement Made In Equity Amount CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, BEGINNING OF PERIOD CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, END OF PERIOD Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Accumulated impairment losses Goodwill, Impaired, Accumulated Impairment Loss CURRENT LIABILITIES: Liabilities, Current [Abstract] Common stock, shares issued (in shares) Common Stock, Shares, Issued Contract liability amounts classified as current Contract with Customer, Liability, Current Effect of Currency Translation Finite-Lived Intangible Assets, Translation Adjustments, Effect On Accumulated Amortization Finite-Lived Intangible Assets, Translation Adjustments, Effect On Accumulated Amortization Interest on lease liabilities Finance Lease, Interest Expense Foreign currency loss, net Foreign Currency Transaction Gain (Loss), before Tax Income Statement Location [Domain] Income Statement Location [Domain] Acquisition-related and integration items, net Acquisition-related and integration items, net Business Combination, Acquisition Related Costs Effect of Currency Translation Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Current finance lease liabilities Finance Lease, Liability, Current Amendment Flag Amendment Flag Intangible life (years) Finite-Lived Intangible Asset, Useful Life Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Operating lease cost Operating Lease, Cost Principal amount Debt Instrument, Face Amount Other Finite-Lived Intangible Assets, Other, Effect On Accumulated Amortization Finite-Lived Intangible Assets, Other, Effect On Accumulated Amortization Number of putative class actions Loss Contingency, Number Of Putative Class Actions Loss Contingency, Number Of Putative Class Actions Investment Type [Axis] Investment Type [Axis] COMPREHENSIVE LOSS Comprehensive Income (Loss), Net of Tax, Attributable to Parent Litigation Case [Axis] Litigation Case [Axis] Accrued interest Liabilities Subject To Compromise, Accrued Interest Liabilities Subject To Compromise, Accrued Interest LIABILITIES SUBJECT TO COMPROMISE Total Liabilities Subject to Compromise Schedule of Reportable Segments Information Schedule of Segment Reporting Information, by Segment [Table Text Block] NET LOSS ATTRIBUTABLE TO DEBTOR ENTITIES Income (Loss) From Continuing Operations Before Equity Method Investments, Income Taxes, Noncontrolling Interest, Net Of Tax Income (Loss) From Continuing Operations Before Equity Method Investments, Income Taxes, Noncontrolling Interest, Net Of Tax Entity Current Reporting Status Entity Current Reporting Status Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] OTHER ASSETS Other Assets, Noncurrent DISCONTINUED OPERATIONS, NET OF TAX (NOTE 4) Discontinued operations, net of tax Loss from discontinued operations, net of tax DISCONTINUED OPERATIONS, NET OF TAX Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Cash payments Payments for Restructuring 5.875% Senior Secured Notes due 2024 Five Point Eight Seven Five Percent Senior Secured Notes Due Twenty Twenty Four [Member] Five Point Eight Seven Five Percent Senior Secured Notes Due Twenty Twenty Four [Member] Adequate protection payments Adequate protection payments Adequate Protection Payments Adequate Protection Payments Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Charges related to rejection and cancellation of equity awards Expenses Related To Equity Agreement Cancellation Expenses Related To Equity Agreement Cancellation Repayments of notes Repayments of Notes Payable Acquisitions, including in-process research and development, net of cash and restricted cash acquired Payments To Acquire Businesses And Asset Acquisitions, Net Of Cash Acquired Payments To Acquire Businesses And Asset Acquisitions, Net Of Cash Acquired Employee severance Employee Severance [Member] Term Loan Facility Term Loan Facility [Member] Term Loan B Facility Due Two Thousand Twenty Four [Member] Counterparty Name [Axis] Counterparty Name [Axis] Schedule of Changes in Qualified Settlement Funds Accounts and Product Liability Balance Schedule of Loss Contingencies by Contingency [Table Text Block] Reorganizations [Abstract] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Other Stockholders' Equity, Other Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Liabilities: Liabilities [Abstract] Effect of foreign exchange rate Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Liabilities subject to compromise, financing lease liability Liabilities Subject To Compromise, Finance Lease Liability Liabilities Subject To Compromise, Finance Lease Liability Accounts payable Liabilities Subject To Compromise, Accounts Payable Liabilities Subject To Compromise, Accounts Payable Operating cash payments for operating leases Operating Lease, Payments Finance lease liabilities Assets and Liabilities, Lessee [Abstract] Changes in fair value recorded in earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Stock options Share-Based Payment Arrangement, Option [Member] OTHER (INCOME) EXPENSE, NET Other Income and Other Expense Disclosure [Text Block] Schedule of Condensed Combined Financial Statements of the Debtors Reorganization, Chapter 11 [Table Text Block] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other miscellaneous, net Other Nonoperating Income (Expense) Carrying Amount Long-Term Debt Foreign currency impact related to the remeasurement of intercompany debt instruments Adjustment for Long-Term Intercompany Transactions, Gross of Tax RESTRUCTURING Restructuring and Related Activities Disclosure [Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized 2017 credit agreement 2017 Credit Agreement [Member] 2017 Credit Agreement [Member] Right-of-use assets: Assets, Noncurrent [Abstract] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Income taxes payable Accrued Income Taxes, Current Maximum Maximum [Member] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Receivables from Non-Debtor Affiliates Due from Affiliate, Current New York NEW YORK Restricted cash and cash equivalents, noncurrent Restricted Cash and Cash Equivalents, Noncurrent Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Contract liabilities - $ change Increase (Decrease) in Contract with Customer, Liability Total current assets Assets, Current Mesh related cases Mesh Related Cases [Member] Mesh Related Cases Contract assets - % change Contract with Customer, Asset, Increase (Decrease), Percentage Contract with Customer, Asset, Increase (Decrease), Percentage Entity Small Business Entity Small Business Measurement Frequency [Domain] Measurement Frequency [Domain] SHAREHOLDERS' DEFICIT Stockholders' Equity Note Disclosure [Text Block] Amount of claims filed Bankruptcy Claims, Amount of Claims Filed SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Chargebacks Accrued Liabilities, Chargebacks, Current Accrued Liabilities, Chargebacks, Current Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Gross consideration payable in installments Resolution Settlement, Gross Consideration Payable In Installments Resolution Settlement, Gross Consideration Payable In Installments Loss from discontinued operations before income taxes Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax Sublease income Sublease Income Net restructuring charges related to: Net restructuring charges included in: Restructuring Charges [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Consolidated Entities [Axis] Consolidated Entities [Axis] Number of cases filed by states Loss Contingency, Claims Filed By States, Number Loss Contingency, Claims Filed By States, Number Subsequent Event [Line Items] Subsequent Event [Line Items] 6.125% Senior Secured Notes due 2029 Six Point One Two Five Percent Senior Notes Due Two Thousand Twenty Nine [Member] Six Point One Two Five Percent Senior Notes Due Two Thousand Twenty Nine Debt Instrument Debt Instrument [Line Items] American Medical Systems American Medical Systems [Member] American Medical Systems [Member] Total operating lease liabilities Operating Lease, Liability Discontinued operations, disposed of by means other than sale, abandonment Discontinued Operations, Disposed of by Means Other than Sale, Abandonment [Member] SEGMENT RESULTS Segment Reporting Disclosure [Text Block] Number of in process research and development projects acquired Number Of In Process Research And Development Projects Acquired Number Of In Process Research And Development Projects Acquired Selling, general and administrative Selling, General and Administrative Expenses [Member] Schedule of Other Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] Entity Address, Country Entity Address, Country Net cash adjustments, excluding interest Tax Adjustments, Settlements, and Unusual Provisions Returns and allowances Accrued Liabilities, Returns And Allowances, Current Accrued Liabilities, Returns And Allowances, Current LIABILITIES AND SHAREHOLDERS’ DEFICIT Liabilities and Equity [Abstract] Net unrealized gain on foreign currency Net unrealized gain on foreign currency Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Settlement, amount awarded to other party Litigation Settlement, Amount Awarded to Other Party WEIGHTED AVERAGE SHARES: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Outstanding principal amount of secured debt, percentage Minimum Ownership Percentage Of Outstanding Secured Debt Threshold, Percentage Minimum Ownership Percentage Of Outstanding Secured Debt Threshold, Percentage Inventories, net Total Inventory, Net Corporate unallocated costs Segment Reporting Information, Unallocated Corporate Expense Segment Reporting Information, Unallocated Corporate Expense Acquisitions Intangible Assets Acquired Intangible Assets Acquired Restructuring charges Restructuring Charges Acquisition-related contingent consideration Acquisition Related Contingent Consideration [Member] Acquisition-Related Contingent Consideration [Member] Continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Auxilium acquisition Auxilium Pharmaceuticals, Inc. [Member] Auxilium Pharmaceuticals, Inc. [Member] Entity Filer Category Entity Filer Category Basic (in shares) For basic per share data—weighted average shares (in shares) Weighted Average Number of Shares Outstanding, Basic SHAREHOLDERS’ DEFICIT: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Restricted Cash and Cash Equivalents [Axis] Restricted Cash and Cash Equivalents [Axis] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Restructuring and related cost, expected number of positions eliminated Restructuring and Related Cost, Expected Number of Positions Eliminated Reserve for loss contingencies Beginning balance Ending balance Loss Contingency Accrual Mesh Liability Accrual Loss Contingency Accrual [Roll Forward] COMMITMENTS AND CONTINGENCIES (NOTE 15) Commitments and Contingencies Segment reconciling items Segment Reconciling Items [Member] TOTAL REVENUES, NET Total net revenues from external customers Revenue from Contract with Customer, Excluding Assessed Tax Number of cases filed by hospitals, health systems, unions, welfare funds or other third-party Loss Contingency, Number Of Cases Filed By Hospitals, Health Systems, Unions, Welfare Funds Or Other Third-Party Loss Contingency, Number Of Cases Filed By Hospitals, Health Systems, Unions, Welfare Funds Or Other Third-Party Operating lease liabilities Liabilities, Noncurrent [Abstract] Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration] Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration] Cover [Abstract] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Level 3 Inputs Fair Value, Inputs, Level 3 [Member] VASOSTRICT® Vasostrict [Member] Vasostrict [Member] Goodwill impairment charges Goodwill, Impairment Loss Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Litigation accruals Liabilities Subject To Compromise, Legal Settlement Accrual Liabilities Subject To Compromise, Legal Settlement Accrual Other Intangible Assets [Line Items] Other Intangible Assets [Line Items] Other Intangible Assets [Line Items] Work-in-process Inventory, Work in Process, Net of Reserves CONTRACT ASSETS AND LIABILITIES Revenue from Contract with Customer [Text Block] Segment Reporting [Abstract] Segment Reporting [Abstract] Contract assets - $ change Increase (Decrease) in Contract with Customer, Asset Accrued royalties and other distribution partner payables Accrued Royalties and Other Distribution Partner Payables, Current Accrued Royalties and Other Distribution Partner Payables, Current Investments [Domain] Investments [Domain] Forecast Forecast [Member] Inventories not yet available for sale Inventory, Not Yet Available For Sale, Net Inventory, Not Yet Available For Sale, Net Interest expense, net Interest Income (Expense), Net Other Other Acquisitions, Excluding Voltaren [Member] Other Acquisitions, Excluding Voltaren Payments of tax withholding for restricted shares Payment, Tax Withholding, Share-Based Payment Arrangement TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT Liabilities and Equity 6.00% Senior Notes due 2028 Six Percent Senior Notes Due Two Thousand Twenty Eight [Member] Six Percent Senior Notes Due Two Thousand Twenty Eight Proceeds from the U.S. Government Agreement Proceeds From U.S. Government Agreement Proceeds From U.S. Government Agreement Amortization of debt issuance cost Amortization of Debt Issuance Costs Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Goodwill Goodwill [Roll Forward] Related Party [Axis] Related Party [Axis] Reorganisation items, net Payments Related To Reorganization Items Net, Operating Activities Payments Related To Reorganization Items Net, Operating Activities Dilutive effect of ordinary share equivalents (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements NET (LOSS) INCOME PER SHARE—DILUTED: Earnings Per Share, Diluted [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Disposal Group Name [Domain] Disposal Group Name [Domain] Level 2 Inputs Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts Payable and Accrued Liabilities Disclosure [Text Block] Diluted (in dollars per share) Earnings Per Share, Diluted OTHER INTANGIBLES, NET Net other intangibles Intangible Assets, Net (Excluding Goodwill) Intangible Assets, Gross Intangible Assets, Gross [Roll Forward] Intangible Assets, Gross [Roll Forward] Compensation related to share-based awards APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Consolidation Items [Axis] Consolidation Items [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Total current liabilities Liabilities, Current Other restructuring charges Other Restructuring [Member] BANKRUPTCY PROCEEDINGS CONDENSED COMBINED DEBTOR-IN-POSSESSION FINANCIAL INFORMATION Reorganization under Chapter 11 of US Bankruptcy Code Disclosure [Text Block] Intangible life (years) Intangible Asset, Useful Life Intangible Asset, Useful Life Ad Hoc First Lien Group Ad Hoc First Lien Group [Member] Ad Hoc First Lien Group Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] DISCONTINUED OPERATIONS AND ASSETS SALES Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Accrual payment period (years) Loss Contingency Accrual Payment, Period Loss Contingency Accrual Payment, Period Asset impairments Asset Impairment Charges [Member] Asset Impairment Charges [Member] Revenue from Contract with Customer Benchmark Revenue from Contract with Customer Benchmark [Member] Income taxes payable/receivable, net Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable Cost Reduction Cost Reduction [Member] Cost Reduction Entity Address, Address Line One Entity Address, Address Line One Cost of revenues Cost of Revenue Contract liabilities Contract with Customer, Liability Product and Service [Axis] Product and Service [Axis] Uncertain tax positions Liabilities Subject To Compromise, Uncertain Tax Positions Liabilities Subject To Compromise, Uncertain Tax Positions Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Disbursements for loans made to Non-Debtor Affiliates Payments to Fund Long-Term Loans to Related Parties Interest expense, net Interest Expense Tradenames Trade Names [Member] Accounts Payable and Accrued Liabilities, Current [Abstract] Accounts Payable and Accrued Liabilities, Current [Abstract] Credit Facility [Axis] Credit Facility [Axis] Long-term inventory Inventory, Noncurrent INVENTORIES Inventory Disclosure [Text Block] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Schedule of Long-Term Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] EQUITY: Equity [Abstract] Subsequent Event [Table] Subsequent Event [Table] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Entity Tax Identification Number Entity Tax Identification Number XIAFLEX® Xiaflex [Member] Xiaflex [Member] Schedule of Goodwill And Other Intangibles [Table] Schedule of Goodwill And Other Intangibles [Table] Schedule of Goodwill and Other Intangibles [Table]. Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Contract with customer, asset, after allowance for credit loss, current Contract with Customer, Asset, after Allowance for Credit Loss, Current Consolidated Entities [Domain] Consolidated Entities [Domain] Increase in contract liability Contract with Customer, Liability, Increase (Decrease) Contract with Customer, Liability, Increase (Decrease) Research and development Research and Development Expense (Excluding Acquired in Process Cost) Mesh Qualified Settlement Funds Settlement Funds [Roll Forward] Settlement Funds [Roll Forward] Operating cash payments for finance leases Finance Lease, Interest Payment on Liability Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fees cap Potential Settlement, Fees Cap Potential Settlement, Fees Cap NET DECREASE IN CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash distributions to settle disputes from Qualified Settlement Funds Loss Contingency Accrual, Payments To Plaintiff Counsel From Qualified Settlement Funds Loss Contingency Accrual, Payments To Plaintiff Counsel From Qualified Settlement Funds Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Schedule of Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Sterile Injectables Sterile Injectables Segment [Member] Sterile Injectables Segment [Member] Discount rate applied Business Combination, Contingent Consideration, Liability, Measurement Input TESTOPEL® Lidoderm [Member] Lidoderm [Member] Entity Central Index Key Entity Central Index Key Measurement Frequency [Axis] Measurement Frequency [Axis] Tax withholding for restricted shares Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] LICENSE, COLLABORATION AND ASSET ACQUISITION AGREEMENTS Collaborative Arrangement Disclosure [Text Block] Specialty Products Specialty Products [Member] Specialty Products [Member] Other Other Accrued Liabilities, Current Measurement Input Type [Axis] Measurement Input Type [Axis] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Entity [Domain] Entity [Domain] City Area Code City Area Code ASSETS Assets: Assets [Abstract] Certain legal costs Legal Fees Impairment of intangible assets Impairment of Intangible Assets (Excluding Goodwill) Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Debt Liabilities Subject to Compromise, Debt and Accrued Interest Amounts Settled and Other Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements And Effect Of Currency Translation Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements And Effect Of Currency Translation FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Acquired in-process research and development Acquired in-process research and development charges Research and Development in Process Share-based compensation Share-Based Payment Arrangement, Noncash Expense Repayments of term loans Repayments of Senior Debt OTHER LIABILITIES Other Liabilities, Noncurrent Net loss from our investments in the equity of other companies EQUITY IN LOSS OF NON-DEBTOR AFFILIATES, NET OF TAX Income (Loss) from Equity Method Investments Payments to plaintiffs and qualified settlement funds Loss Contingency Accrual, Payments Disposal Group Classification [Domain] Disposal Group Classification [Domain] Capital expenditures, excluding capitalized interest Payments to Acquire Property, Plant, and Equipment Asset impairment charges Asset impairments Asset Impairment Charges Disaggregation of Revenue Disaggregation of Revenue [Line Items] Established Products Established Products [Member] Established Products [Member] Research and development Research and Development Expense [Member] Stock awards Stock Award [Member] Stock Award [Member] Weighted average Weighted Average [Member] Schedule of Reconciliation of the Numerator and Denominator of Basic and Diluted Net (Loss) Income Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Texas TEXAS Other sales deductions Accrued Liabilities, Other Sales Deductions, Current Accrued Liabilities, Other Sales Deductions, Current Cost of revenues Cost of Sales [Member]